Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 25 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 25 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 24 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Amerikaanse FDA kent weesgeneesmiddelstatus toe aan Gamgertamig voor de behandeling van Pemphigus | 20103010 Biotechnology | Other subject |
| 24 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront ontvangt transparantieverklaring van Bank of America | 20103010 Biotechnology | Other subject |
| 24 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront Receives Transparency Notification from Bank of America | 20103010 Biotechnology | Other subject |
| 24 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus | 20103010 Biotechnology | Other subject |
| 18 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Share history |
| 18 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Share history |
| 12 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 12 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 10 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront Biotherapeutics rapporteert halfjaarcijfers 2026 en geeft een update over de activiteiten | 20103010 Biotechnology | Other subject |
| 10 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update | 20103010 Biotechnology | Other subject |
| 04 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 04 Aug 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 28 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 28 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 21 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 21 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 14 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 14 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 13 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi | 20103010 Biotechnology | Other subject |
| 13 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront kondigt het terugtreden van Paulo Fontoura uit de Raad van Bestuur aan na zijn benoeming tot Global Head of Research & Development bij Sanofi | 20103010 Biotechnology | Other subject |
| 07 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 07 Jul 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 30 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 30 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 29 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront Receives Transparency Notification from Madison Avenue Partners | 20103010 Biotechnology | Change in Capital |
| 29 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront ontvangt transparantieverklaring van Madison Avenue Partners | 20103010 Biotechnology | Change in Capital |
| 23 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 23 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 16 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Inkoop van eigen aandelen | 20103010 Biotechnology | Other subject |
| 16 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Acquisition of Own Shares | 20103010 Biotechnology | Other subject |
| 09 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront kondigt start aan van aandeleninkoopprogramma ter waarde van € 50 miljoen | 20103010 Biotechnology | Other subject |
| 09 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront Announces Initiation of €50 Million Stock Repurchase Program | 20103010 Biotechnology | Other subject |
| 08 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer | 20103010 Biotechnology | New |
| 08 Jun 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront benoemt dr. Eric Hedrick tot Chief Medical Officer | 20103010 Biotechnology | New |
| 04 Jun 2026 22:15 CEST |
LAKEFRONT BIOTHERAPEUTICS | GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN | 20103010 Biotechnology | Other subject |
| 04 Jun 2026 22:15 CEST |
LAKEFRONT BIOTHERAPEUTICS | GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE | 20103010 Biotechnology | Other subject |
| 26 May 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront ontvangt transparantieverklaring van Bank of America | 20103010 Biotechnology | Other subject |
| 26 May 2026 22:01 CEST |
LAKEFRONT BIOTHERAPEUTICS | Lakefront Receives Transparency Notification from Bank of America | 20103010 Biotechnology | Other subject |
| 06 May 2026 22:01 CEST |
GALAPAGOS | Galapagos rapporteert financiële resultaten over het eerste kwartaal van 2026 en geeft bedrijfsupdate | 20103010 Biotechnology | Other subject |
| 06 May 2026 22:01 CEST |
GALAPAGOS | Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update | 20103010 Biotechnology | Other subject |
| 28 Apr 2026 22:01 CEST |
GALAPAGOS | Aandeelhouders van Galapagos keuren alle door de Raad van Bestuur voorgestelde besluiten goed op de Gewone en Buitengewone Algemene Vergaderingen van 2026 | 20103010 Biotechnology | Other subject |
| 28 Apr 2026 22:01 CEST |
GALAPAGOS | Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026 | 20103010 Biotechnology | Other subject |
| 31 Mar 2026 07:30 CEST |
GALAPAGOS | Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases | 20103010 Biotechnology | Other subject |
| 31 Mar 2026 07:30 CEST |
GALAPAGOS | Galapagos en Gilead gaan definitieve overeenkomst aan over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen | 20103010 Biotechnology | Other subject |
| 26 Mar 2026 21:02 CET |
GALAPAGOS | Galapagos Announces Nomination of Gino Santini to its Board of Directors | 20103010 Biotechnology | Other subject |
| 26 Mar 2026 21:02 CET |
GALAPAGOS | Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Raad van Bestuur | 20103010 Biotechnology | Other subject |
| 26 Mar 2026 21:01 CET |
GALAPAGOS | Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings | 20103010 Biotechnology | Other subject |
| 26 Mar 2026 21:01 CET |
GALAPAGOS | Galapagos publiceert 2025 jaarverslag en kondigt de Gewone (jaarlijkse) en Buitengewone Algemene Vergaderingen aan | 20103010 Biotechnology | Other subject |